Skip to main content

Emerging Therapies

Emerging Therapies

Novel Drug “Home Run” for TRK Mutation–Positive Tumors

Emerging Therapies

Novel Hypomethylating Agent Active in Patients with High-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Emerging Therapies

Glasdegib, a Hedgehog Inhibitor, Nearly Doubles Survival in AML or High-Risk MDS

Emerging Therapies

The Hematology Pipeline Features New Immune Therapies, and Targeted Agents

Emerging Therapies

CAR T-Cell Therapy Succeeds in Aggressive Lymphoma

Emerging Therapies

Plethora of Targeted Agents in the Oncology Pipeline

Emerging Therapies

Biosimilar to Trastuzumab Shows Equivalent Efficacy and Safety

Emerging Therapies

Novel Vaccine Induces Immunologic Responses in Patients with Acute Myeloid Leukemia

Emerging Therapies

New Standard in Elderly Patients with Glioblastoma Based on Phase 3 Evidence

Emerging Therapies

Novel Chimeric Monoclonal Antibody Improves Survival in Advanced Gastric Cancers

1
2
3
4
5
6

Page 3 of 7
Results 21 - 30 of 67